US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist
  • 1.3850
  • +0.0450+3.36%
Close Nov 8 16:00 ET
2.09MMarket Cap-73P/E (TTM)

About Dermata Therapeutics Company

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.

Company Profile

SymbolDRMA
Company NameDermata Therapeutics
Listing DateAug 13, 2021
Issue Price6.99
Founded2014
CEOMr. Gerald T. Proehl
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address3525 Del Mar Heights Road,Suite 322
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-800-2543
Websitehttp://www.dermatarx.com

Company Executives

  • Name
  • Position
  • Salary
  • Gerald T. Proehl
  • Chairman of the Board, President and Chief Executive Officer
  • 392.00K
  • Kyri K. Van Hoose
  • Senior Vice President, Principal Accounting Officer and Chief Financial Officer
  • 442.25K
  • Dr. Christopher J. Nardo, PhD
  • Senior Vice President and Chief Development Officer
  • 469.97K
  • Dr. Maria Bedoya Toro Munera, PhD
  • Senior Vice President, Regulatory Affairs and Quality Assurance
  • --
  • Kathleen D. Scott
  • Independent Director
  • 55.00K
  • Brittany K. Bradrick
  • Independent Director
  • 47.50K
  • David F. Hale
  • Lead Independent Director
  • 73.00K
  • Dr. Steven J. Mento,PhD
  • Independent Director
  • 44.00K
  • Mary M. Fisher
  • Independent Director
  • 47.50K
  • Dr. Wendell D. Wierenga,PhD
  • Independent Director
  • 50.00K
  • Dr. Andrew Seth Sandler, M.D.
  • Independent Director
  • 49.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data